Paul Hartmann AG
Paul Hartmann AG manufactures and sells medical and care products in Germany, the rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Incontinence Management, Wound Care, and Infection Management. It offers absorbent underwear, incontinence pads and pants, and fixation pants; medical skincare products; wound management p… Read more
Paul Hartmann AG (PHH2) - Net Assets
Latest net assets as of June 2025: €1.17 Billion EUR
Based on the latest financial reports, Paul Hartmann AG (PHH2) has net assets worth €1.17 Billion EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€2.15 Billion) and total liabilities (€978.01 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €1.17 Billion |
| % of Total Assets | 54.52% |
| Annual Growth Rate | 5.74% |
| 5-Year Change | 22.88% |
| 10-Year Change | 57.56% |
| Growth Volatility | 3.71 |
Paul Hartmann AG - Net Assets Trend (2013–2024)
This chart illustrates how Paul Hartmann AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Paul Hartmann AG (2013–2024)
The table below shows the annual net assets of Paul Hartmann AG from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €1.20 Billion | +7.22% |
| 2023-12-31 | €1.12 Billion | -1.16% |
| 2022-12-31 | €1.13 Billion | +3.26% |
| 2021-12-31 | €1.09 Billion | +12.29% |
| 2020-12-31 | €973.33 Million | +4.39% |
| 2019-12-31 | €932.40 Million | +1.00% |
| 2018-12-31 | €923.15 Million | +7.99% |
| 2017-12-31 | €854.84 Million | +4.73% |
| 2016-12-31 | €816.21 Million | +7.52% |
| 2015-12-31 | €759.10 Million | +9.96% |
| 2014-12-31 | €690.37 Million | +6.70% |
| 2013-12-31 | €647.04 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Paul Hartmann AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 78.6% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €108.45 Million | 9.44% |
| Other Components | €1.04 Billion | 90.56% |
| Total Equity | €1.15 Billion | 100.00% |
Paul Hartmann AG Competitors by Market Cap
The table below lists competitors of Paul Hartmann AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Lafarge Malayan Cement Bhd
KLSE:3794
|
$776.34 Million |
|
EMPLOYERS HLDGS DL -01
F:YGB
|
$776.36 Million |
|
Generation Development Group Ltd
AU:GDG
|
$776.64 Million |
|
Workspace Group plc
PINK:WKPPF
|
$776.67 Million |
|
Myers Industries Inc
NYSE:MYE
|
$776.12 Million |
|
Hangzhou Zhongtai Cryogenic Technology Corp
SHE:300435
|
$775.01 Million |
|
Levima Advanced Materials Corp
SHE:003022
|
$774.90 Million |
|
Gansu Jiu Steel Group Hongxing Iron & Steel Co Ltd
SHG:600307
|
$774.08 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Paul Hartmann AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,063,397,000 to 1,148,549,000, a change of 85,152,000 (8.0%).
- Net income of 108,452,000 contributed positively to equity growth.
- Dividend payments of 28,414,000 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €108.45 Million | +9.44% |
| Dividends Paid | €28.41 Million | -2.47% |
| Other Changes | €5.11 Million | +0.45% |
| Total Change | €- | 8.01% |
Book Value vs Market Value Analysis
This analysis compares Paul Hartmann AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.66x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.92x to 0.66x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €230.70 | €213.00 | x |
| 2018-12-31 | €248.81 | €213.00 | x |
| 2019-12-31 | €250.15 | €213.00 | x |
| 2020-12-31 | €261.34 | €213.00 | x |
| 2021-12-31 | €293.69 | €213.00 | x |
| 2022-12-31 | €303.78 | €213.00 | x |
| 2023-12-31 | €299.40 | €213.00 | x |
| 2024-12-31 | €323.38 | €213.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Paul Hartmann AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.44%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.50%
- • Asset Turnover: 1.15x
- • Equity Multiplier: 1.83x
- Recent ROE (9.44%) is above the historical average (8.69%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 9.24% | 3.19% | 1.51x | 1.91x | €-4.72 Million |
| 2014 | 11.10% | 3.94% | 1.50x | 1.88x | €7.28 Million |
| 2015 | 10.85% | 4.05% | 1.52x | 1.76x | €6.19 Million |
| 2016 | 10.87% | 4.28% | 1.49x | 1.70x | €6.80 Million |
| 2017 | 10.76% | 4.28% | 1.44x | 1.75x | €6.21 Million |
| 2018 | 8.94% | 3.73% | 1.41x | 1.70x | €-9.36 Million |
| 2019 | 6.56% | 2.66% | 1.36x | 1.81x | €-30.58 Million |
| 2020 | 11.47% | 4.38% | 1.41x | 1.86x | €13.66 Million |
| 2021 | 9.08% | 4.11% | 1.26x | 1.75x | €-9.64 Million |
| 2022 | 3.35% | 1.56% | 1.15x | 1.86x | €-71.75 Million |
| 2023 | 2.67% | 1.21% | 1.18x | 1.87x | €-77.92 Million |
| 2024 | 9.44% | 4.50% | 1.15x | 1.83x | €-6.40 Million |
Industry Comparison
This section compares Paul Hartmann AG's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $10,481,995,211
- Average return on equity (ROE) among peers: 4.27%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Paul Hartmann AG (PHH2) | €1.17 Billion | 9.24% | 0.83x | $776.29 Million |
| Modern Dental Group Limited (1MD) | $2.36 Billion | 15.30% | 0.55x | $193.75 Million |
| SCHOTT Pharma AG & Co. KGaA (1SXP) | $709.04 Million | 17.68% | 0.69x | $482.88 Million |
| Alcon Inc. (2U3) | $19.26 Billion | 1.95% | 0.45x | $33.73 Billion |
| Shofu Inc. (69W) | $35.51 Billion | 8.83% | 0.23x | $215.32 Million |
| 7VG (7VG) | $176.36 Million | 14.92% | 1.12x | $684.88 Million |
| Bio-gate AG (BIG1) | $4.25 Million | -42.46% | 0.46x | $2.79 Million |
| Sartorius AG VZO O.N. (SRT) | $497.08 Million | 9.76% | 1.56x | $6.78 Billion |
| Shandong Weigao Group Medical Polymer Company Limited (UK2) | $25.34 Billion | 8.16% | 0.37x | $1.36 Billion |